National Institute of Allergy and Infectious Diseases

National Institute of Allergy and Infectious Diseases

First New HIV Vaccine Efficacy Study in Seven Years Underway

Health International
The first HIV vaccine efficacy study to launch anywhere in seven years is now testing whether an experimental vaccine regimen safely prevents HIV infection among South African adults. ...
Read more 0

Women’s Interagency HIV Study Marks 20 Years

Health
The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, established the WIHS in 1993 in response to a dramatic increase in AIDS cases among women in the United States. Since then, the WIHS has enrolled a total of 4,137 women who were HIV-infected or at risk for acquiring HIV, and has published more than 550 scientific papers. ...
Read more 0

NIAID Awards 14 Grants for HIV Vaccine Research

NIAID Awards 14 Grants for HIV Vaccine Research
The grants were awarded under the Innovation for HIV Vaccine Discovery initiative, which is expected to receive up to $34.8 million over the next four years. ...
Read more 0

HIV Superinfection in Uganda More Common Than Originally Thought, New Study

HIV Superinfection in Uganda More Common Than Originally Thought, New Study
HIV superinfection in Uganda may be more common than previously thought, study finds. ...
Read more 0